Colorectal cancer
A cancer that starts in the colon or the rectum, parts of the large bowel. Signs include blood in your poo, changes in your usual bowel habits, tummy pain and losing weight without trying. Surgery is the most common treatment for colon cancer. You may also have chemotherapy, radiotherapy, targeted medicines or immunotherapy. The risk grows with age, and screening tests from about 45 can help find it early, when it may be easier to treat.
Read more about colorectal cancerTrial-stage treatments and research studies you can join
Filters
- Tests zongertinib alone or with other drugs in HER2-positive cancers that have spread
Tests zongertinib, alone or combined, in adults with HER2-positive cancers that have spread.
A Coruña, SpainAlso Barcelona, L'Hospitalet de Llobregat, Madrid, Seville, ValenciaAge 18+ - Tests GSK5460025 alone or combined with other drugs in solid tumors
Tests the pill GSK5460025 in adults with certain solid tumors that have specific genetic traits.
Barcelona, SpainAlso MadridAge 18+ - Tests VVD-133214 with pembrolizumab in advanced colorectal cancer
Tests VVD-133214 plus pembrolizumab in adults with advanced colorectal cancer with MSI or dMMR.
Barcelona, SpainAlso Madrid, Málaga, Santiago de Compostela, ValenciaAge 18+ - Tests encorafenib with cetuximab again in BRAF-mutant bowel cancer
Tests encorafenib plus cetuximab in adults with BRAF-mutant advanced colorectal cancer.
Barcelona, SpainAge 18+ - SOT109 for advanced colorectal cancer that cannot be removed by surgery or has spread
Tests SOT109, aimed at CDH17 cancer cells, in adults with advanced colorectal cancer.
Barcelona, SpainAge 18+ - Tests VVD-133214 alone or with other drugs in advanced solid tumors
Tests VVD-133214, a pill, in adults with advanced solid tumors.
Barcelona, SpainAlso Madrid, Pamplona, ValenciaAge 18+ - Tests PLN-101095 with pembrolizumab in adults with advanced solid tumors
Tests PLN-101095, alone and with pembrolizumab, in adults with solid tumors that progressed on immunotherapy.
Barcelona, SpainAlso Logroño, MadridAge 18+ - Tests calderasib with chemotherapy and cetuximab in colorectal cancer
Tests calderasib with chemotherapy in adults with KRAS G12C colorectal cancer.
Badalona, SpainAlso Barcelona, Las Palmas de Gran Canaria, Madrid, Oviedo, Santander, ValenciaAge 18+ - Pembrolizumab and porustobart before surgery for colon cancer that can be removed
Tests pembrolizumab with porustobart before surgery in adults with colon cancer.
Barcelona, SpainAlso L'Hospitalet de Llobregat, MadridAge 18+ - Tests VS-7375 in adults with advanced solid tumors carrying a KRAS G12D mutation
Tests the drug VS-7375, alone or combined, in adults with advanced KRAS G12D-mutated cancers.
Barcelona, SpainAlso Logroño, MadridAge 18+ - IDE034 for Advanced Solid Tumors Including Lung, Colorectal, Ovarian and Prostate Cancers
Tests IDE034 in adults with advanced solid tumors that carry B7-H3 and PTK7.
Madrid, SpainAge 18+ - Testing Targeted Treatments in Metastatic Colorectal Cancer by Tumor Marker
Tests targeted drugs and immunotherapy in adults with colorectal cancer that has spread.
Barcelona, SpainAlso Madrid, Majadahonda, Valencia, ZaragozaAge 18+ - Tests ivonescimab with chemotherapy against bevacizumab for colorectal cancer
Compares ivonescimab plus chemotherapy with bevacizumab plus chemotherapy in adults with metastatic colorectal cancer.
A Coruña, SpainAlso Barcelona, Córdoba, Granada, Madrid, Málaga, Palma de Mallorca, Santander, Seville, …Age 18+ - PF-08032562 for advanced breast cancer and colorectal cancer
Tests PF-08032562 alone or with other treatments in adults with advanced breast or colorectal cancer.
Barcelona, SpainAlso Madrid, ValenciaAge 18+ - New treatments tested in adults with colorectal cancer that has spread after earlier treatment
Compares precemtabart tocentecan with or without bevacizumab against standard treatment in colorectal cancer.
Barcelona, SpainAlso Córdoba, Madrid, ValenciaAge 18+ - Tests Sofe-M in adults with selected advanced solid tumors
Tests whether Sofe-M is safe and tolerable in adults with advanced solid tumors.
Barcelona, SpainAlso Madrid, ValenciaAge 18+ - Tests zanidatamab in adults with HER2-expressing solid tumors that were previously treated
Tests zanidatamab in adults whose tumors overexpress HER2 and were treated before.
Barcelona, SpainAlso Las Palmas, Madrid, Málaga, Pamplona, ValenciaAge 18+ - Tests sevabertinib in solid tumors with HER2 gene mutations
Tests sevabertinib tablets in adults with solid tumors carrying HER2 mutations.
Barcelona, SpainAlso L'Hospitalet de Llobregat, MadridAge 18+ - Tests LY4257496 radioligand therapy in adults with advanced GRPR-positive cancers
Tests LY4257496, a targeted radiation drug, in adults with advanced GRPR-positive solid tumors.
Barcelona, SpainAlso MadridAge 18+ - Tests amivantamab alone and with chemotherapy in advanced colorectal cancer
Tests amivantamab, alone or with chemotherapy, in adults with advanced colorectal cancer.
Barcelona, SpainAlso Madrid, Santander, ValenciaAge 18+
Trials that have ended are not listed here, because nobody can join them. Stopped and finished Colorectal cancer trials (research view)
Where treatment stands
In the EU, fruquintinib got its first authorisation in June 2024.
Approved: 26
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 64
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 5
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Lab research stage: 2
Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The EU medicines agency (EMA), ClinicalTrials.gov and the EU trials register, checked on 10 November 2026. Every treatment links to its own records; the texts are written by AI from them.
Medicines approved only in single countries are not included. We did not check in which countries a medicine is sold or paid for. Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 473 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for colorectal cancer. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.
Support organisations
Patient organisations and helplines in Spain, for you and your family.
Colorectal cancer organisations in Spain
- Asociación Española Contra el Cáncer (AECC)
Free Infocáncer line, 24 hours a day, 7 days a week, with support for patients and families.
- Afalynch – Asociación de familias con síndrome de Lynch
Spanish association of families with Lynch syndrome (hereditary colorectal cancer risk) focused on information and family prevention.
General support in Spain
- Línea 024 de atención a la conducta suicida
Spain's free 24/7 national helpline 024 of the Ministry of Health for people with suicidal thoughts and their relatives.
- Teléfono de la Esperanza
Spanish non-profit offering a free, confidential crisis and emotional support line and mental health promotion across Spain.
International organisations
Offer tissue or data
There are three ways to help research move faster.
Approved treatments
26 medicines are approved for colorectal cancer in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.
Checked on 11 Nov 2026 in the official lists of the US (FDA), the EU (EMA), Japan (PMDA, approvals since April 2004), Switzerland (Swissmedic), France (ANSM, medicines approved in France only) and Taiwan (TFDA). For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. 11 uncertain matches are left out. Other countries' own approvals were not checked.
“Miracle cure” fact checker
Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
“Cures” others already fact-checked
- Fenbendazole & Colorectal cancer
- NOUS-209 neoantigen vaccine & Colorectal cancer
- CBD (cannabidiol) & Colorectal cancer
- Vitamin C (incl. high-dose) & Colorectal cancer
About colorectal cancer
Sources: NHS, NCI PDQ, MedlinePlus, NCI SEER
A cancer that starts in the colon or the rectum, parts of the large bowel. Signs include blood in your poo, changes in your usual bowel habits, tummy pain and losing weight without trying. Surgery is the most common treatment for colon cancer. You may also have chemotherapy, radiotherapy, targeted medicines or immunotherapy. The risk grows with age, and screening tests from about 45 can help find it early, when it may be easier to treat.
What is it?
Bowel cancer, also called colorectal cancer, is cancer anywhere in the large bowel: the colon or the rectum. The large bowel takes water from food and gets rid of waste. It is one of the most common cancers.
The risk grows with age, and you are more likely to get it if you are over 50. It is most often found in people aged 65 to 74. It is more likely if a close relative has had bowel cancer, or if you have an inherited condition such as Lynch syndrome or familial adenomatous polyposis (FAP). Crohn's disease or ulcerative colitis, bowel polyps (small growths), smoking and being overweight also raise the risk. Eating more fruit and vegetables, less red and processed meat, being active and drinking less alcohol can lower it.
The first signs
Bowel cancer may not cause signs at first.
- changes in their poo that are not usual for them, such as softer poo, diarrhoea or constipation;
- needing to poo more or less often than usual;
- blood in their poo, which can look red or black, or bleeding from the bottom;
- often feeling they need to poo, even just after going to the toilet;
- tummy pain, a lump in the tummy or bloating;
- losing weight without trying.
Feeling very tired or short of breath can be a sign of anaemia, which can be caused by bowel cancer. These signs often have other causes.
How doctors find out
If your family doctor thinks you could have bowel cancer, they send you to a specialist. The main test is a colonoscopy: a thin, bendy tube with a camera looks inside your bowel. It may be uncomfortable but should not hurt, and you are offered a sedative and painkillers. A small piece of the bowel lining (a biopsy) can be taken for testing. Stool tests that look for hidden blood are also used.
If it is cancer, CT, MRI or PET scans, blood tests and gene tests show how far it has spread and whether certain gene changes are involved. This helps your team choose the treatment. A specialist nurse is your main contact during and after treatment.
Current treatment
Surgery, often with chemotherapy or radiotherapy
Will it get worse?
It depends on how big the cancer is, whether it has spread, and your general health. About 23 in 100 bowel cancers have spread to other parts of the body when they are found. The outlook also depends on whether surgery can remove all of the tumour and whether the bowel is blocked.
Advanced bowel cancer can be hard to treat. Then treatment aims to slow the cancer, ease symptoms and help you live longer, and a palliative care team helps with symptoms and comfort. After treatment you have check-ups and tests. A blood test called CEA may be done to see whether the cancer has come back.
Medicines: what helps, and what to watch for
Chemotherapy is medicine that kills cancer cells. You may have it before surgery to shrink the cancer, after surgery to lower the chance of it coming back, instead of surgery, or when the cancer has spread. For advanced bowel cancer, targeted medicines can stop or slow its growth, and immunotherapy helps your immune system attack it. Biomarker tests can help predict how you will respond to certain targeted medicines.
Good to know:
- Most people get some side effects of chemotherapy, but not all of them. Common ones are tiredness, feeling sick, a sore mouth, diarrhoea or constipation, hair loss that is usually temporary, and numbness or tingling in the hands or feet;
- Your team explains the benefits and side effects of each treatment and helps you manage them.
Exercise and diet after surgery
If you have a stoma after surgery (see below), start with gentle activity, such as a short walk, when you feel ready. Once your bowel has settled, go back to your usual, balanced food.
Surgery and radiotherapy
Surgery is the most common treatment at every stage of colon cancer. The surgeon removes the cancer and some of the bowel around it. If the cancer is in a polyp, the polyp is often removed during a colonoscopy. The surgeon may then join the two healthy ends of the bowel back together. If the ends cannot be joined, a stoma (an opening on the outside of the body for waste to pass through) is made, and a bag collects the waste. It can be temporary or permanent.
Radiotherapy uses beams of radiation to kill cancer cells. It is used for cancer in the rectum and for cancer that has spread. If the cancer has spread to the liver, those parts may be removed by surgery. If you cannot have surgery, they may be destroyed with heat or by freezing.
Is there a cure?
Your outlook and treatment depend on the stage of the cancer. Bowel cancer found early, for example through screening, may be easier to treat. Advanced bowel cancer that has spread may be hard to treat and not possible to cure. New treatments are being tested in clinical trials.
Median survival
About 29 to 30 months with first-line treatment, once it has spread
Measured in: Previously untreated metastatic colorectal cancer with KRAS wild-type tumours: the CALGB/SWOG 80405 trial (2,334 patients)
The figures behind it
NCI PDQ (health professional, colon), CALGB/SWOG 80405 (2,334 previously untreated patients with KRAS wild-type metastatic colorectal cancer): median overall survival 29.04 months with chemotherapy plus bevacizumab and 29.93 months with chemotherapy plus cetuximab; the difference was not statistically significant.
Sources
Written in plain words by Frontlight from these pages:
- NHS: Bowel cancer – What is bowel cancer?
- NHS: Bowel cancer – Symptoms
- NCI PDQ: Colon Cancer Treatment (PDQ) – Patient Version
- MedlinePlus: Colorectal Cancer
- NHS: Bowel cancer – Causes
- NCI SEER: Cancer Stat Facts: Colorectal Cancer
- NHS: Bowel cancer – Tests and next steps
- NHS: Bowel cancer – Treatment
- NHS: Chemotherapy – Side effects
- NHS: Colostomy – Recovery and lifestyle changes
- NCI PDQ: Colon Cancer Treatment (PDQ®) – Health Professional Version